Lung deposition of budesonide from turbuhaler in asthmatic children. 1998

J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
Department of Respiratory Medicine, Princess Margaret Hospital for Children, Subiaco, WA, Australia. hannesw@cyllene.uwa.edu.au

The aim of our study was to evaluate the effect of age on lung deposition of radiolabelled budesonide, delivered as a dry powder via Turbuhaler to asthmatic children. A group of 23 asthmatic children, aged 6 to 16 years, with relatively stable asthma inhaled 99mTc-labelled budesonide from a dry powder inhaler (Turbuhaler). Body and lung deposition was assessed using a gamma camera. The mean (range) median peak inspiratory flow during inhalation was 65 1 x min(-1) (45 to 76 1 x min(-1)). Mean (range) total lung deposition of 99mTc-labelled budesonide, expressed as a percentage of the metered dose, was 29.1% (15.6-47.2%) and was positively and significantly correlated with age, height and peak inspiratory flow. CONCLUSIONS Total lung deposition of radiolabelled budesonide from a dry powder inhaler (Turbuhaler), is age dependent in children with moderate asthma. However, lung deposition is still satisfactory, even in younger children with lower peak inspiratory flows.

UI MeSH Term Description Entries
D007320 Inspiratory Capacity The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the TIDAL VOLUME and the INSPIRATORY RESERVE VOLUME. Common abbreviation is IC. Capacities, Inspiratory,Capacity, Inspiratory,Inspiratory Capacities
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D009330 Nebulizers and Vaporizers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Atomizers,Inhalation Devices,Inhalators,Inhalers,Vaporizers,Nebulizers,Vaporizers and Nebulizers,Atomizer,Device, Inhalation,Devices, Inhalation,Inhalation Device,Inhalator,Inhaler,Nebulizer,Vaporizer
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
September 2001, Respiratory medicine,
J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
October 2003, American journal of respiratory and critical care medicine,
J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
September 1997, The European respiratory journal,
J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
December 1995, The European respiratory journal,
J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
October 1994, The European respiratory journal,
J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
January 1994, The European respiratory journal,
J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
October 2001, American journal of respiratory and critical care medicine,
J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
January 1998, The Medical letter on drugs and therapeutics,
J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
August 2002, Respiratory medicine,
J H Wildhaber, and S G Devadason, and J M Wilson, and C Roller, and T Lagana, and L Borgström, and P N LeSouëf
April 1994, The European respiratory journal,
Copied contents to your clipboard!